Article
Multiple Mutation Detection for Risk Assessment in Patients with Breast Cancer by Using Next-Generation Sequencing.
Annals of clinical and laboratory science - 1 Sept 2021
Liu Peng-Fei, Zhuo Zhong-Ling, Xie Fei, Xian Hai-Peng, Liu Chang, Wang Shu, Zhao Xiao-Tao
Abstract excerpt
OBJECTIVE: Breast cancer is recognized as the most common cause of malignancy and cancer death worldwide; however, mutations in the cancer-related BRCA genes are detected in only 2-3% of patients with breast cancer. Because next-generation sequencing technology allows concurrent sequencing of numerous target genes, diverse cancer-susceptibility genes are now being evaluated, although their significance in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
